stella
beta
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD — Stella
Home
/
Chronic Hepatitis b
/
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
View on ClinicalTrials.gov
Recruiting
Back to Chronic Hepatitis b trials
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
Trial locations
(1 site)
China
Nanjing Drum Tower Hospital, Nanjing